Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

79645

registered interest
date	28/07/2014
answering body	Department for Education
answering dept id	60
answering dept short name	Education
answering dept sort name	Education
hansard heading	Schools: Radicalism
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government whether, in the review commissioned by the Secretary of State for Education into whether the Department missed historical warnings in respect of concerns raised about Birmingham schools, the Permanent Secretary intends to interview Lord Hunt of Kings Heath.
tabling member printed	Lord Hunt of Kings Heath
uin	HL1537
answer	answer is ministerial correction date of answer 30/07/2014 answer text <p>Given that the Permanent Secretary’s review is ongoing, it would not be appropriate to comment on details regarding the conduct of the review. The Permanent Secretary will be reporting to the Secretary of State later in the summer.</p> answering member printed Lord Nash grouped question UIN HL1536 question first answered 30/07/2014 13:50:47 answering member 4270 label Biography information for Lord Nash
tabling member	2024 label Biography information for Lord Hunt of Kings Heath

79467

registered interest
date	22/07/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Health Services: Disability
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government what assessment they have made of current measures and the compliance of the National Health Service in ensuring that all official paperwork and all types of communication are adapted appropriately for people with sensory disabilities.
tabling member printed	Lord Hunt of Kings Heath
uin	HL1366
answer	answer is ministerial correction date of answer 29/07/2014 answer text <p>The Department has not made any such assessment.</p><p> </p><p>NHS England is committed to the development and implementation of a new information standard for accessible information and communication.</p><p> </p><p>ISB 1605 Accessible Information aims to establish a consistent, standardised framework and approach to the identification and recording of the information and communication needs of patients, service users, carers and parents, where they relate to a disability, impairment or sensory loss; establish ‘flags’, alerts, prompts and other mechanisms to ensure that such needs are highly visible to appropriate staff; and set out clear expectations as to how such needs should be met, supported or addressed.</p><p> </p><p>Final approval of the standard is scheduled for Spring 2016. Following the announcement, organisations are currently anticipated to have 12 months to achieve full compliance.</p> answering member printed Earl Howe question first answered 29/07/2014 13:14:28 answering member 2000 label Biography information for Earl Howe
tabling member	2024 label Biography information for Lord Hunt of Kings Heath

79468

registered interest
date	22/07/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Gastrointestinal Cancer
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government what is their assessment of the current National Health Service ability to meet the needs of paediatric, adolescent, wild-type and syndromic gastrointestinal stromal tumour cancer patients.
tabling member printed	Lord Hunt of Kings Heath
uin	HL1367
answer	answer is ministerial correction date of answer 29/07/2014 answer text <p>This Government wants England to lead the world in tackling cancer and ensure the National Health Service is able to meet the needs of all cancer patients. That is why our 2011 Cancer Outcomes Strategy set the ambition to save a further 5,000 lives a year from cancer by 2014-15. The Strategy is backed with more than £750 million over the four year Spending Review period (2011-12 to 2014-15).</p><p> </p><p>A number of treatments have been recommended by the National Institute for Health and Care Excellence (NICE) for the treatment of gastrointestinal stromal tumour (GIST) including the paediatric, adolescent, wild-type and syndromic (PAWS) sub-variants.</p><p> </p><p>NHS commissioners are legally required to fund treatments recommended by NICE in its technology appraisal guidance. NICE regularly reviews its guidance to take into account new evidence.</p><p> </p><p>Treatment for PAWS GIST is commissioned through NHS England’s Specialised Services. Treatment for individuals is managed through multi-disciplinary teams. GIST Support UK have in partnership with Addenbrookes Hospital in Cambridge, established a PAWS-GIST clinic that is led by Dr Bulusu working with a United Kingdom national alliance of doctors. NHS England, through its Children’s Cancer and Sarcoma Clinical Reference Groups, is monitoring the clinic as it develops and progresses.</p><p> </p><p>We know how important it is for patients to receive the information they need and a range of initiatives have been used in the NHS, such as information prescriptions, advanced communications training and support for clinical nurse specialists.</p><p> </p><p>NICE guidance on improving outcomes in children and young people with cancer also emphasises the importance of providing patients, families and carers with the information they need.</p><p> </p><p>NHS England has no plans to develop a National Service Framework for paediatric, adolescent, wild-type and syndromic gastrointestinal stromal tumour.</p> answering member printed Earl Howe grouped question UIN HL1368 HL1369 HL1371 question first answered 29/07/2014 13:23:05 answering member 2000 label Biography information for Earl Howe
tabling member	2024 label Biography information for Lord Hunt of Kings Heath

79469

registered interest
date	22/07/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Gastrointestinal Cancer
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government whether they will develop a National Service Framework for paediatric, adolescent, wild-type and syndromic gastrointestinal stromal tumour cancer patients.
tabling member printed	Lord Hunt of Kings Heath
uin	HL1368
answer	answer is ministerial correction date of answer 29/07/2014 answer text <p>This Government wants England to lead the world in tackling cancer and ensure the National Health Service is able to meet the needs of all cancer patients. That is why our 2011 Cancer Outcomes Strategy set the ambition to save a further 5,000 lives a year from cancer by 2014-15. The Strategy is backed with more than £750 million over the four year Spending Review period (2011-12 to 2014-15).</p><p> </p><p>A number of treatments have been recommended by the National Institute for Health and Care Excellence (NICE) for the treatment of gastrointestinal stromal tumour (GIST) including the paediatric, adolescent, wild-type and syndromic (PAWS) sub-variants.</p><p> </p><p>NHS commissioners are legally required to fund treatments recommended by NICE in its technology appraisal guidance. NICE regularly reviews its guidance to take into account new evidence.</p><p> </p><p>Treatment for PAWS GIST is commissioned through NHS England’s Specialised Services. Treatment for individuals is managed through multi-disciplinary teams. GIST Support UK have in partnership with Addenbrookes Hospital in Cambridge, established a PAWS-GIST clinic that is led by Dr Bulusu working with a United Kingdom national alliance of doctors. NHS England, through its Children’s Cancer and Sarcoma Clinical Reference Groups, is monitoring the clinic as it develops and progresses.</p><p> </p><p>We know how important it is for patients to receive the information they need and a range of initiatives have been used in the NHS, such as information prescriptions, advanced communications training and support for clinical nurse specialists.</p><p> </p><p>NICE guidance on improving outcomes in children and young people with cancer also emphasises the importance of providing patients, families and carers with the information they need.</p><p> </p><p>NHS England has no plans to develop a National Service Framework for paediatric, adolescent, wild-type and syndromic gastrointestinal stromal tumour.</p> answering member printed Earl Howe grouped question UIN HL1367 HL1369 HL1371 question first answered 29/07/2014 13:23:05 answering member 2000 label Biography information for Earl Howe
tabling member	2024 label Biography information for Lord Hunt of Kings Heath

79470

registered interest
date	22/07/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Gastrointestinal Cancer
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government what information is made available to patients about paediatric, adolescent, wild-type and syndromic gastrointestinal stromal tumours.
tabling member printed	Lord Hunt of Kings Heath
uin	HL1369
answer	answer is ministerial correction date of answer 29/07/2014 answer text <p>This Government wants England to lead the world in tackling cancer and ensure the National Health Service is able to meet the needs of all cancer patients. That is why our 2011 Cancer Outcomes Strategy set the ambition to save a further 5,000 lives a year from cancer by 2014-15. The Strategy is backed with more than £750 million over the four year Spending Review period (2011-12 to 2014-15).</p><p> </p><p>A number of treatments have been recommended by the National Institute for Health and Care Excellence (NICE) for the treatment of gastrointestinal stromal tumour (GIST) including the paediatric, adolescent, wild-type and syndromic (PAWS) sub-variants.</p><p> </p><p>NHS commissioners are legally required to fund treatments recommended by NICE in its technology appraisal guidance. NICE regularly reviews its guidance to take into account new evidence.</p><p> </p><p>Treatment for PAWS GIST is commissioned through NHS England’s Specialised Services. Treatment for individuals is managed through multi-disciplinary teams. GIST Support UK have in partnership with Addenbrookes Hospital in Cambridge, established a PAWS-GIST clinic that is led by Dr Bulusu working with a United Kingdom national alliance of doctors. NHS England, through its Children’s Cancer and Sarcoma Clinical Reference Groups, is monitoring the clinic as it develops and progresses.</p><p> </p><p>We know how important it is for patients to receive the information they need and a range of initiatives have been used in the NHS, such as information prescriptions, advanced communications training and support for clinical nurse specialists.</p><p> </p><p>NICE guidance on improving outcomes in children and young people with cancer also emphasises the importance of providing patients, families and carers with the information they need.</p><p> </p><p>NHS England has no plans to develop a National Service Framework for paediatric, adolescent, wild-type and syndromic gastrointestinal stromal tumour.</p> answering member printed Earl Howe grouped question UIN HL1367 HL1368 HL1371 question first answered 29/07/2014 13:23:05 answering member 2000 label Biography information for Earl Howe
tabling member	2024 label Biography information for Lord Hunt of Kings Heath

79472

registered interest
date	22/07/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Gastrointestinal Cancer
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government what their assessment is of the treatment available for paediatric, adolescent, wild-type and syndromic gastrointestinal stromal tumour cancer patients.
tabling member printed	Lord Hunt of Kings Heath
uin	HL1371
answer	answer is ministerial correction date of answer 29/07/2014 answer text <p>This Government wants England to lead the world in tackling cancer and ensure the National Health Service is able to meet the needs of all cancer patients. That is why our 2011 Cancer Outcomes Strategy set the ambition to save a further 5,000 lives a year from cancer by 2014-15. The Strategy is backed with more than £750 million over the four year Spending Review period (2011-12 to 2014-15).</p><p> </p><p>A number of treatments have been recommended by the National Institute for Health and Care Excellence (NICE) for the treatment of gastrointestinal stromal tumour (GIST) including the paediatric, adolescent, wild-type and syndromic (PAWS) sub-variants.</p><p> </p><p>NHS commissioners are legally required to fund treatments recommended by NICE in its technology appraisal guidance. NICE regularly reviews its guidance to take into account new evidence.</p><p> </p><p>Treatment for PAWS GIST is commissioned through NHS England’s Specialised Services. Treatment for individuals is managed through multi-disciplinary teams. GIST Support UK have in partnership with Addenbrookes Hospital in Cambridge, established a PAWS-GIST clinic that is led by Dr Bulusu working with a United Kingdom national alliance of doctors. NHS England, through its Children’s Cancer and Sarcoma Clinical Reference Groups, is monitoring the clinic as it develops and progresses.</p><p> </p><p>We know how important it is for patients to receive the information they need and a range of initiatives have been used in the NHS, such as information prescriptions, advanced communications training and support for clinical nurse specialists.</p><p> </p><p>NICE guidance on improving outcomes in children and young people with cancer also emphasises the importance of providing patients, families and carers with the information they need.</p><p> </p><p>NHS England has no plans to develop a National Service Framework for paediatric, adolescent, wild-type and syndromic gastrointestinal stromal tumour.</p> answering member printed Earl Howe grouped question UIN HL1367 HL1368 HL1369 question first answered 29/07/2014 13:23:06 answering member 2000 label Biography information for Earl Howe
tabling member	2024 label Biography information for Lord Hunt of Kings Heath

79140

registered interest
date	21/07/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Assistive Technology
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government what measures they are taking to ensure that there is equality of access to disability assistive technology systems in different parts of the country.
tabling member printed	Lord Hunt of Kings Heath
uin	HL1301
answer	answer is ministerial correction date of answer 29/07/2014 answer text <p>NHS England is responsible for the oversight of commissioning of Assistive Technology by the National Health Service.</p><p> </p><p>NHS England advises that it is committed to improving and assuring the continued development of assistive technology through the publication and monitoring against national service specifications. It recognises the potential of assistive technologies to improve health outcomes, empower patients to self-manage their conditions, and provide care that is convenient, accessible and cost-effective. The Technology Enabled Care Services (TECS) programme at NHS England aims to improve the lives of people with long-term conditions through the use of technologies such as telehealth, telecare, telemonitoring, telecoaching and self-care apps. The ambition is to create the right commissioning environment that supports and encourages the innovative use of technology to improve health outcomes and deliver more cost effective services.</p><p> </p><p>NHS England has also identified an additional £22.5 million funding for Augmentative and Alternative Communication and Environmental Controls in 2014-15. It is currently engaged with clinicians and service providers to ensure equitable and timely access to these services for the population of England.</p> answering member printed Earl Howe grouped question UIN HL1305 question first answered 29/07/2014 11:48:42 answering member 2000 label Biography information for Earl Howe
tabling member	2024 label Biography information for Lord Hunt of Kings Heath

79141

registered interest
date	21/07/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Wheelchairs
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government what assessment they have made of the National Health Service wheelchair voucher scheme.
tabling member printed	Lord Hunt of Kings Heath
uin	HL1302
answer	answer is ministerial correction date of answer 29/07/2014 answer text <p>The Government has not made any assessments relating to the wheelchair voucher scheme. NHS England is leading work with all groups involved in wheelchair services to improve current services.</p> answering member printed Earl Howe grouped question UIN HL1303 HL1304 question first answered 29/07/2014 11:42:49 answering member 2000 label Biography information for Earl Howe
tabling member	2024 label Biography information for Lord Hunt of Kings Heath

79142

registered interest
date	21/07/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Wheelchairs
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government what the approval process is for mobility aids and wheelchairs to be approved for use under the National Health Service wheelchair voucher scheme; and whether they consider that it allows sufficient patient choice.
tabling member printed	Lord Hunt of Kings Heath
uin	HL1303
answer	answer is ministerial correction date of answer 29/07/2014 answer text <p>The Government has not made any assessments relating to the wheelchair voucher scheme. NHS England is leading work with all groups involved in wheelchair services to improve current services.</p> answering member printed Earl Howe grouped question UIN HL1302 HL1304 question first answered 29/07/2014 11:42:49 answering member 2000 label Biography information for Earl Howe
tabling member	2024 label Biography information for Lord Hunt of Kings Heath

79143

registered interest
date	21/07/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Wheelchairs
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government what assessment they have made of the impact of the power of local National Health Service providers to set their own level of the National Health Service wheelchair vouchers on levels of access to the scheme in different areas<b></b>.
tabling member printed	Lord Hunt of Kings Heath
uin	HL1304
answer	answer is ministerial correction date of answer 29/07/2014 answer text <p>The Government has not made any assessments relating to the wheelchair voucher scheme. NHS England is leading work with all groups involved in wheelchair services to improve current services.</p> answering member printed Earl Howe grouped question UIN HL1302 HL1303 question first answered 29/07/2014 11:42:48 answering member 2000 label Biography information for Earl Howe
tabling member	2024 label Biography information for Lord Hunt of Kings Heath